Microcirculation 2008
DOI: 10.1016/b978-0-12-374530-9.00007-3
|View full text |Cite
|
Sign up to set email alerts
|

Receptor-Mediated Events in the Microcirculation

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
3
0

Year Published

2008
2008
2024
2024

Publication Types

Select...
4
1
1

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(3 citation statements)
references
References 742 publications
(569 reference statements)
0
3
0
Order By: Relevance
“…M4 receptors were detected in the forebrain, hippocampus and striatum, they are likely involved in pain processes [ 30 ]. The physiological action of M5 receptors is not yet elucidated, however, it is assumed that these receptors are involved in brain microcirculation and mediate vasoconstriction, vasodilatation and activation of nitric oxide synthase [ 31 ].…”
Section: Pharmacology Of Tas and Their Role As Drug Lead Substancementioning
confidence: 99%
“…M4 receptors were detected in the forebrain, hippocampus and striatum, they are likely involved in pain processes [ 30 ]. The physiological action of M5 receptors is not yet elucidated, however, it is assumed that these receptors are involved in brain microcirculation and mediate vasoconstriction, vasodilatation and activation of nitric oxide synthase [ 31 ].…”
Section: Pharmacology Of Tas and Their Role As Drug Lead Substancementioning
confidence: 99%
“…The changes in vital signs and derived parameters as well as the clinically significant elevation in SBP and or HR in about 18% of the 51 study participants could be attributed to stimulation of cardiac β -1 adrenergic receptors. Dopamine in moderate doses stimulates cardiac β -1 adrenoreceptors resulting in a positive inotropic effect and a vasodilation that manifest, itself clinically as an increase in SBP with insignificant change in DBP [ 35 ]. This line of reasoning explains our findings of test drug induced clinically relevant vital signs changes starting on days 6-7 of the UPT period onwards (1.5–2 mg/day).…”
Section: Discussionmentioning
confidence: 99%
“…For more extensive details relating to receptor subtypes, details of signal transduction and actions in the microcirculation, see reference[405]. For more extensive details relating to receptor subtypes, details of signal transduction and actions in the microcirculation, see reference[405].…”
mentioning
confidence: 99%